Bill Text: TX SB1606 | 2017-2018 | 85th Legislature | Introduced
Bill Title: Relating to the dispensing of aesthetic pharmaceuticals by physicians; authorizing fees.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2017-03-21 - Referred to Health & Human Services [SB1606 Detail]
Download: Texas-2017-SB1606-Introduced.html
85R7025 BEE-F | ||
By: Creighton | S.B. No. 1606 |
|
||
|
||
relating to the dispensing of aesthetic pharmaceuticals by | ||
physicians; authorizing fees. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Section 157.002(f), Occupations Code, is amended | ||
to read as follows: | ||
(f) Subsections (b) and (c) do not authorize a physician or | ||
a person acting under the supervision of a physician to keep a | ||
pharmacy, advertised or otherwise, for the retail sale of dangerous | ||
drugs, other than as authorized under Section 158.003 and | ||
Subchapter B, Chapter 158, without complying with the applicable | ||
laws relating to the dangerous drugs. | ||
SECTION 2. Chapter 158, Occupations Code, is amended by | ||
designating Sections 158.001, 158.002, and 158.003, Occupations | ||
Code, as Subchapter A, Chapter 158, Occupations Code, and adding a | ||
subchapter heading to read as follows: | ||
SUBCHAPTER A. PROVISION OF DRUGS AND SUPPLIES UNDER CERTAIN | ||
CIRCUMSTANCES | ||
SECTION 3. Chapter 158, Occupations Code, is amended by | ||
adding Subchapter B to read as follows: | ||
SUBCHAPTER B. DISPENSING OF AESTHETIC PHARMACEUTICALS | ||
Sec. 158.051. DEFINITION. In this subchapter, "aesthetic | ||
pharmaceutical" means: | ||
(1) a drug listed in the aesthetic pharmaceutical | ||
group under Section 158.055; or | ||
(2) a drug that: | ||
(A) is not a controlled substance; | ||
(B) requires a prescription for dispensation; | ||
(C) is legally marketed under 21 U.S.C. Section | ||
355, if it is a new drug subject to that section; and | ||
(D) is prescribed for the enhancement of an | ||
individual's appearance. | ||
Sec. 158.052. DISPENSING PERMITTED; FEE AUTHORIZED. A | ||
physician may dispense to the physician's patients an aesthetic | ||
pharmaceutical in excess of the patient's immediate needs without | ||
obtaining a license under Chapter 558. The physician may charge a | ||
fee for dispensing the pharmaceutical. | ||
Sec. 158.053. NOTICE; LABELING; RECORDKEEPING. (a) Before | ||
dispensing an aesthetic pharmaceutical to a patient, a physician | ||
must inform the patient that the prescription for the | ||
pharmaceutical may be filled at a pharmacy, if available at a | ||
pharmacy, or dispensed in the physician's office. | ||
(b) Each state and federal labeling and recordkeeping | ||
requirement applicable to an aesthetic pharmaceutical must be | ||
followed and documented. A record maintained under this section | ||
must be accessible as provided under state and federal law. | ||
Sec. 158.054. RULES; FEES. The board shall adopt rules to | ||
govern the packaging, labeling, and dispensing of aesthetic | ||
pharmaceuticals under this subchapter. The board shall adopt | ||
reasonable fees as necessary to implement this subchapter. A fee | ||
adopted under this section may not exceed a fee adopted under | ||
Section 554.006 for authorizing a pharmacist to dispense | ||
pharmaceuticals. | ||
Sec. 158.055. AESTHETIC PHARMACEUTICAL GROUP. The | ||
aesthetic pharmaceutical group consists of: | ||
(1) bimatoprost; | ||
(2) hydroquinone; | ||
(3) tretinoin; | ||
(4) metronidazole; | ||
(5) tazarotene; | ||
(6) eflornithine; | ||
(7) dapsone; | ||
(8) salicylic acid; | ||
(9) topical medications containing urea; | ||
(10) mequinol; and | ||
(11) resorcinol. | ||
SECTION 4. Section 563.051(d), Occupations Code, is amended | ||
to read as follows: | ||
(d) This section does not authorize a physician or a person | ||
acting under the supervision of a physician to keep a pharmacy, | ||
advertised or otherwise, for the retail sale of dangerous drugs, | ||
other than as authorized under Section 158.003 and Subchapter B, | ||
Chapter 158, without complying with the applicable laws relating to | ||
the dangerous drugs. | ||
SECTION 5. The Texas Medical Board shall adopt rules for the | ||
implementation of Subchapter B, Chapter 158, Occupations Code, as | ||
added by this Act, not later than January 1, 2018. | ||
SECTION 6. (a) Except as provided by Subsection (b) of this | ||
section, this Act takes effect immediately if it receives a vote of | ||
two-thirds of all the members elected to each house, as provided by | ||
Section 39, Article III, Texas Constitution. If this Act does not | ||
receive the vote necessary for immediate effect, this Act takes | ||
effect September 1, 2017. | ||
(b) Sections 158.052 and 158.053, Occupations Code, as | ||
added by this Act, take effect July 1, 2018. |